Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 2/20 | 0.51 |
| ▸ | BTK | Q06187 | 1/20 | 0.48 |
| ▸ | USP30 | Q70CQ3 | 5/20 | 0.46 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.45 |
| ▸ | STS | P08842 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | IDH1 | O75874 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29124439 | 1.00 | PIK3CD (0.51) | PIK3CDBTKUSP30RIPK1SYK | |
| SCHEMBL7178421 | 1.00 | PIK3CD (0.51) | PIK3CDBTKUSP30RIPK1SYK | |
| SCHEMBL7178416 | 1.00 | PIK3CD (0.51) | PIK3CDBTKUSP30RIPK1SYK | |
| SCHEMBL29124358 | 0.87 | PIK3CD (0.53) | PIK3CDBTKUSP30PIK3CAADORA1 | |
| SCHEMBL29124357 | 0.87 | PIK3CD (0.53) | PIK3CDBTKUSP30PIK3CAADORA1 | |
| SCHEMBL31170908 | 0.87 | PIK3CD (0.53) | PIK3CDBTKUSP30PIK3CAADORA1 | |
| SCHEMBL2636499 | 0.86 | PIK3CD (0.52) | PIK3CDBTKUSP30HSD11B1PIK3CA | |
| SCHEMBL2636502 | 0.86 | PIK3CD (0.52) | PIK3CDBTKUSP30HSD11B1PIK3CA | |
| SCHEMBL21811035 | 0.85 | PIK3CD (0.43) | PIK3CDBTKCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL21811034 | 0.85 | PIK3CD (0.43) | PIK3CDBTKCYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240425504-A1 | IMIDAZOPYRIDINONE COMPOUND | KISSEI PHARMACEUTICAL CO., LTD. (assignee) (JP) | 2024-12-26 | — | — | US | disclosed |
| EP-3808747-B1 | IMIDAZOPYRIDINONE COMPOUND | KISSEI PHARMACEUTICAL (JP) | 2024-12-18 | — | — | EP | disclosed |
| US-12077531-B2 | Imidazopyridinone compound | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2024-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12077531-B2 | Imidazopyridinone compound | EGLN3, DHPS, EGLN2 | PIK3CD 2844/4885BTK 1827/4885USP30 716/4885 |
| US-20240425504-A1 | IMIDAZOPYRIDINONE COMPOUND | EGLN3, DHPS, EGLN2 | PIK3CD 2844/4885BTK 1827/4885USP30 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.